Integrated Safety Analysis of Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor, in Relapsed/Refractory Lymphoid Malignancies

Drug Category: Array
Conference Category: Array
Lead Author: Davids M, et al.
Published Date: 21/09/2021
Download Link: https://pubmed.ncbi.nlm.nih.gov/34547767/
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top